Compass Pathways is engaging commercial insurers and CMS regarding reimbursement mechanisms for clinical monitoring required during COMP360 psilocybin treatment sessions.
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
From the article
Compass Pathways CEO: Psychedelics company will 'go slow before we go fast'
5
52c7ae14
Article
Compass Pathways CEO: Psychedelics company will 'go slow before we go fast'
0